| D-16 Joćo Abrantes Model-informed development of RG6102, an amyloid-targeting investigational drug with enhanced brain penetration properties Tuesday 16:55-17:15 |
| D-16 Joćo Abrantes Model-informed development of RG6102, an amyloid-targeting investigational drug with enhanced brain penetration properties Tuesday 16:55-17:15 |